NORTHVALE, N.J., June 6, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (“Elite”) (OTCBB:ELTP) today announced that it has entered into a commercial Manufacturing and Supply Agreement with Mikah Pharma, LLC (“Mikah”). Under the terms of the agreement, Elite will perform the laboratory stability studies, manufacturing and packaging for two generic products: Isradipine Capsules USP, 2.5 mg and 5 mg and Phendimetrazine Tartrate Tablets USP, 35 mg.
